person · Reporting owner
Nolan Mangini Siobhan
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alight, Inc. / DelawareALIT · Entity 5436 | Director | July 02, 2026 | July 07, 2026 |
| CASTLIGHT HEALTH, INC.CSLT · Entity 130187 | President | February 16, 2020 | February 19, 2020 |
| NGM BIOPHARMACEUTICALS INCNGM · Entity 11997 | President and CFO | March 02, 2023 | March 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alight, Inc. / Delaware
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,153 |
Reported balance
After 2026-07-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-02 · Grant · Acquired 14,025 · Balance 17,153 F1: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027. F2: Includes restricted stock units scheduled to vest in the future. F3: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted for annual board service, pursuant to the Issuer's 2021 Omnibus Share Plan, which are scheduled to vest on July 2, 2027.
F2: Includes restricted stock units scheduled to vest in the future.
F3: Securities listed in this filing have been adjusted to reflect a 1-for-20 reverse split of the Issuer's Class A common stock effective as of June 30, 2026.
CASTLIGHT HEALTH, INC.
Report date February 16, 2020 · Filed February 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 438,998 |
Ending reported balance
After 2020-02-18 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2020-02-16 · Exercise / conversion · Acquired 1,875 · Balance 391,765 Row 2 · 2020-02-16 · Exercise / conversion · Acquired 15,625 · Balance 407,390 Row 3 · 2020-02-16 · Exercise / conversion · Acquired 6,250 · Balance 413,640 Row 4 · 2020-02-16 · Exercise / conversion · Acquired 11,250 · Balance 424,890 Row 5 · 2020-02-16 · Exercise / conversion · Acquired 23,063 · Balance 447,953 Row 6 · 2020-02-16 · Exercise / conversion · Acquired 25,862 · Balance 473,815 Row 7 · 2020-02-18 · Sale · Disposed 34,817 · Balance 438,998 F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-02-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-02-16 · Exercise / conversion · Disposed 1,875 · Balance 0 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 31,250 |
Reported balance
After 2020-02-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-02-16 · Exercise / conversion · Disposed 15,625 · Balance 31,250 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 25,000 |
Reported balance
After 2020-02-16 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-02-16 · Exercise / conversion · Disposed 6,250 · Balance 25,000 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 90,010 |
Reported balance
After 2020-02-16 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-02-16 · Exercise / conversion · Disposed 11,250 · Balance 90,010 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 276,750 |
Reported balance
After 2020-02-16 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-02-16 · Exercise / conversion · Disposed 23,063 · Balance 276,750 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 362,069 |
Reported balance
After 2020-02-16 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-02-16 · Exercise / conversion · Disposed 25,862 · Balance 362,069 F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
F4: 1/4th of the RSUs vested on February 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F5: 1/4th of the RSUs vested on August 16, 2017, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F6: 1/4th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F7: 1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F8: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F9: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
NGM BIOPHARMACEUTICALS INC
Report date March 02, 2023 · Filed March 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,000 |
Reported balance
After 2023-03-02 transaction · row 1
1 source rowRow 1 · 2023-03-02 · Grant · Acquired 76,000 · Balance 76,000 F1: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2033-03-01 | Direct | 228,000 |
Reported balance
After 2023-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-02 · Grant · Acquired 228,000 · Balance 228,000 F2: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 · Expires 2033-03-01 | Direct | 200,000 |
Reported balance
After 2023-03-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-02 · Grant · Acquired 200,000 · Balance 200,000 F3: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
F2: The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
F3: 1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F5 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · derivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Class B Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F4 · derivative.exercise_date: 25% of the RSUs vested on November 16, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F4 · derivative.expiration_date: 25% of the RSUs vested on November 16, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:14 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017370 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 18:37 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017209 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F5 · derivative.exercise_date: 25% of the RSUs vested on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F5 · derivative.expiration_date: 25% of the RSUs vested on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 18:37 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017209 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 17, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 21,756 | $3.42 | $74,392.47 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,887 F7 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.27 to $3.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 16, 2019 Filed May 17, 2019 17:17 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 649 | $3.66 | $2,375.28 |
DisclosureSEC source: 0001567619-19-011570 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,081 F2 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.61 to $3.66 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 23,062 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · derivative · entry 13 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,938 Underlying: Class B Common Stock · 23,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on April 5, 2019, the grant of which was previously reported by the Reporting Person on a Form 4. F15 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F15 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · derivative · entry 12 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,750 Underlying: Class B Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. F14 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F14 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · derivative · entry 11 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 Underlying: Class B Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F4 · kind: Release and settlement of RSUs granted to the Reporting Person on March 7, 2017, the grant of which was previously reported by the Reporting Person on a Form 4. F13 · derivative.exercise_date: 25% of the RSUs will vest on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F13 · derivative.expiration_date: 25% of the RSUs will vest on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,125 Underlying: Class B Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F3 · kind: Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4. F12 · derivative.exercise_date: 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F12 · derivative.expiration_date: 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · derivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. F11 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F11 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · derivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Class B Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F10 · derivative.exercise_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F10 · derivative.expiration_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on April 5, 2019, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Release and settlement of RSUs granted to the Reporting Person on March 7, 2017, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:38 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011700 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| May 15, 2019 Filed May 17, 2019 17:17 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011570 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F5 · derivative.exercise_date: 25% of the RSUs vested on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F5 · derivative.expiration_date: 25% of the RSUs vested on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| May 15, 2019 Filed May 17, 2019 17:17 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-011570 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| April 05, 2019 Filed Apr 9, 2019 17:45 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantRestricted Stock Units · Derivative | 369,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-008634 · doc1.xml · derivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,000 Underlying: Class B Common Stock · 369,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F2 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 20, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 15,248 | $3.14 | $47,816.20 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,855 F8 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.08 to $3.25 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 1,036 | $3.29 | $3,411.44 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 8 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,103 F8 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $3.245 to $3.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 16 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Class B Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F7 · kind: Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. F18 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F18 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 15 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class B Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on March 7, 2017, the grant of which was previously reported by the Reporting Person on a Form 4. F17 · derivative.exercise_date: 25% of the RSUs will vest on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F17 · derivative.expiration_date: 25% of the RSUs will vest on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 14 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,750 Underlying: Class B Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4. F16 · derivative.exercise_date: 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F16 · derivative.expiration_date: 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 13 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F4 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. F15 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F15 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 12 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Class B Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F3 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F14 · derivative.exercise_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F14 · derivative.expiration_date: 25% of the RSUs vested on November 16, 2016 and the remainder vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 7 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 6 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: Release and settlement of RSUs granted to the Reporting Person on March 7, 2017, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 5 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 4 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 16, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Release and settlement of RSUs granted to the Reporting Person on November 16, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 11 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Class B Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F13 · derivative.exercise_date: 25% of the RSUs vested on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F13 · derivative.expiration_date: 25% of the RSUs vested on August 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · derivative · entry 10 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. F12 · derivative.exercise_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F12 · derivative.expiration_date: 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Release and settlement of RSUs granted to the Reporting Person on August 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:22 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005032 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 16:59 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 11,319 | $2.21 | $25,070.45 |
DisclosureSEC source: 0001567619-19-000326 · doc1.xml · nonDerivative · entry 2 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,139 F2 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of restricted stock units over several days. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.19 to $2.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:59 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 33,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-000326 · doc1.xml · derivative · entry 3 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,600 Underlying: Class B Common Stock · 33,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. F5 · derivative.exercise_date: 33.3% of the RSUs vested on December 31, 2018, 33.3% of the RSUs will vest on December 31, 2019 and the remaining 33.3% of the RSUs will vest on December 31, 2020. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F5 · derivative.expiration_date: 33.3% of the RSUs vested on December 31, 2018, 33.3% of the RSUs will vest on December 31, 2019 and the remaining 33.3% of the RSUs will vest on December 31, 2020. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:59 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 33,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-000326 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. Read SEC document |
| November 19, 2018 Filed Nov 20, 2018 18:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 13,997 | $2.62 | $36,648.35 |
DisclosureSEC source: 0001567619-18-006811 · doc1.xml · nonDerivative · entry 1 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,058 F1 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of restricted stock units over several days. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $2.55 to $2.68 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 17, 2018 Filed Nov 19, 2018 19:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 579 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-006701 · doc1.xml · derivative · entry 17 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F10 · kind: Release and settlement of RSUs granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. F19 · derivative.exercise_date: 25% of the RSUs vested on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F19 · derivative.expiration_date: 25% of the RSUs vested on February 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| November 17, 2018 Filed Nov 19, 2018 19:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 579 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-006701 · doc1.xml · nonDerivative · entry 9 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · kind: Release and settlement of RSUs granted to the Reporting Person on November 17, 2014, the grant of which was previously reported by the Reporting Person on a Form 3. Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 19:09 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-006701 · doc1.xml · derivative · entry 16 Nolan Mangini Siobhan · CIK 0001679464 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,250 Underlying: Class B Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F9 · kind: Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4. F18 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F18 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.